Australia markets open in 35 minutes

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.8100-0.1000 (-2.04%)
At close: 4:00PM EDT
4.8100 0.00 (0.00%)
After hours: 05:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.9100
Open4.9200
Bid4.8100 x 1400
Ask4.8800 x 1000
Day's range4.7100 - 4.9214
52-week range3.7100 - 8.7400
Volume59,859
Avg. volume104,110
Market cap48.673M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.1890
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Acurx Presents Positive Ibezapolstat Microbiome Data from Its Phase 2a Trial at IDWeek

    Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that a scientific abstract and poster were presented on September 29th at the Infectious Disease Society of America (IDSA) IDWeek™ 2021 Virtual Conference entitled: "An Open-label Phase 2a study of Ibezapolstat, a Unique Gram-positive Selective Spectrum (GPSS™) Antibiotic, for Patients

  • PR Newswire

    Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021

    The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations, today announced that 10 of its member companies will present data from their clinical and research programs at IDWeek 2021 taking place virtually from September 29-October 3, 2021. AWG members are presenting a total of 23 poster presentations and 3 oral abstract presentations.

  • PR Newswire

    Acurx Pharmaceuticals to Participate in the A.G.P. Biotech and Specialty Pharma Conference October 13, 2021

    Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that management will participate in the A.G.P. Biotech and Specialty Pharma Conference on October 13 2021.